BRO stock forecast, quote, news & analysis

Key Takeaways

• Brown & Brown (BRO) shares traded near $67.66 in late July 2026, reflecting a modest gain of approximately 5.4% over the trailing 30-day period and a notable climb from levels around $57 observed at the start of June.
• The company's blockbuster Accession acquisition contributed roughly $445 million in Q1 2026 revenues, propelling total quarterly revenue up 35.4% year-over-year to $1.9 billion and surpassing Wall Street expectations.
• Analyst sentiment remains sharply divided: Citizens JMP raised its price target to $78 while maintaining a Market Outperform rating, and Mizuho reiterated a Buy with an $81 target, yet Morgan Stanley downgraded the stock to Underweight with a $55 target, citing organic growth concerns and a softer insurance pricing cycle.
• Q2 2026 earnings are scheduled for release after market close on July 27, with consensus estimates of $1.08 per share on $1.72 billion in revenue, representing approximately 34% top-line growth from the prior-year quarter.
• Broader insurance brokerage industry headwinds — including moderating rate increases, elevated catastrophe exposure in property lines, and intensifying middle-market competition — remain key variables shaping investor sentiment toward BRO.

Current Market Snapshot

Brown & Brown shares have exhibited a volatile but upwardly biased trajectory through mid-2026. After starting June around the $57 level, the stock rallied sharply in the final week of June and into early July, touching highs near $70 before pulling back to the mid-$60s. The pullback coincided with Morgan Stanley's July 6 downgrade to Underweight, which cited weakening organic growth momentum and elevated sensitivity to Florida property markets. The stock subsequently recovered ground following Citizens' price-target increase to $78 on July 10 and Mizuho's reaffirmed Buy rating at $81 on July 13. As of the most recent trading session on July 24, BRO closed at $67.66. The broader insurance brokerage sector faces a late-cycle pricing environment, with property insurance rates softening and casualty reserve adequacy drawing increased analyst scrutiny — factors that continue to color the stock's near-term narrative.

Brown & Brown (BRO) Business Overview and Competitive Position

Brown & Brown, Inc. is one of the largest independent insurance brokerage firms in the United States, delivering property and casualty, employee benefits, personal risk, and specialty insurance solutions since 1939. Headquartered in Daytona Beach, Florida, the company operates through more than 700 locations worldwide with a workforce of approximately 23,000 professionals. Its business is organized into two primary segments: Retail, which provides insurance products and risk management services directly to commercial, public sector, and individual clients, and Specialty Distribution (including wholesale brokerage and programs), which connects carriers and intermediaries to niche markets. Brown & Brown has built a formidable competitive moat through a disciplined acquisition strategy — completing 725 insurance intermediary acquisitions from 1993 through Q1 2026 — most notably the transformative Accession acquisition that dramatically expanded the firm's scale. The company has also raised its dividend for 33 consecutive years, underscoring steady capital returns alongside growth. With a market capitalization of approximately $23 billion and a forward P/E of roughly 14.4x — below the insurance brokerage industry average of about 16.4x — BRO occupies a distinctive position as a value-oriented name within a sector where peers like AON and AJG often command premium multiples.

Recent Developments Driving BRO

The most consequential recent development for Brown & Brown has been the integration of the Accession acquisition, which contributed approximately $445 million in recognized revenues during Q1 2026 alone. Total revenues of $1.90 billion beat the consensus estimate of $1.89 billion, while adjusted EPS of $1.39 exceeded the $1.36 forecast. However, organic revenue growth excluding contingent commissions remained subdued at 1.0% in Retail and turned negative at -2.0% in Specialty Distribution, reflecting headwinds from prior-year flood claim comparisons and a pharmacy revenue-model transition. Management guided for sequential organic improvement through 2026 and projected $30–$40 million in Accession EBITDA synergies for the year. On the analyst front, the divergence is stark: Morgan Stanley's July 6 downgrade to Underweight with a $55 target spotlighted concerns about a softening pricing cycle, middle-market competition, and elevated Florida property exposure. Conversely, Citizens JMP raised its target to $78 on July 10, and Mizuho maintained Buy at $81 on July 13, both emphasizing BRO's discounted valuation and long-term compounding record. The company also announced strategic leadership appointments — including Neil Krauter Sr. as executive managing director for growth and specialization, and Corey Lewis as retail global head of tax insurance — signaling continued investment in specialized capabilities. Insider activity has been net positive, with director Joia Johnson purchasing shares in the open market during the period.

Trending AI Robots

For traders seeking data-driven insights beyond conventional equity analysis, Tickeron's Trending AI Robots page offers a curated window into algorithmic trading strategies actively deployed across the market. Tickeron operates hundreds of AI-powered trading bots covering thousands of tickers, but only the highest-performing and most relevant bots earn placement in this featured section. Each bot employs distinct strategies, timeframes, and performance benchmarks — ranging from short-term momentum plays to longer-duration trend-following approaches — allowing users to explore diverse algorithmic perspectives. Whether complementing fundamental research or surfacing trading signals that human analysis might overlook, the Trending AI Robots section provides a real-time snapshot of what quantitative models are signaling across the current market landscape.

2026 Outlook and What Investors Should Watch

Looking ahead, the immediate catalyst for Brown & Brown is its Q2 2026 earnings report and the accompanying management commentary during the July 28 conference call. Investors will scrutinize organic growth trends, contingent commission performance, Accession synergy realization, and margin trajectory — particularly whether the ~200 basis point EBITDAC drag from Accession integration narrows as guided. The broader insurance pricing cycle represents the dominant macro variable: property insurance rate increases are decelerating, and several casualty lines face pressure, which could compress commission growth industry-wide. Brown & Brown's elevated exposure to Florida and catastrophe-prone property markets amplifies sensitivity to hurricane season activity in the second half of 2026. On the positive side, the company's robust M&A pipeline, AI-driven operational efficiency initiatives (including automated submission processing and billing platforms saving over 50,000 hours annually), and strong free cash flow generation — over $260 million in Q1 alone — provide meaningful offsets. The consensus full-year 2026 EPS estimate stands at approximately $4.50 on roughly $7.05 billion in revenue, implying 5.9% EPS growth and 19.5% revenue expansion. For 2027, analysts project EPS of about $4.87 on $7.42 billion in revenue. Key risks to monitor include further analyst estimate revisions, interest expense pressure from elevated acquisition-related debt, and competitive intensity in middle-market insurance brokerage.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations